EP3825306
Morfínanefnasambönd
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
30.4.2008EP published:
7.6.2023EP application number:
20200633.4
EP translation filed:
26.6.2023Grant published:
15.7.2023EPO information:
European Patent Register
Max expiry date:
29.4.2028Expiry date:
29.4.2026Next due date:
30.4.2026
Title in English:
MORPHINAN COMPOUNDSLanguage of the patent:
English
Timeline
Today
30.4.2008EP application
7.6.2023EP Publication
26.6.2023Translation submitted
15.7.2023Registration published
29.4.2026Expires
Owner
Name:
Sun Pharmaceutical Industries, Inc.Address:
2 Independence Way, Princeton, NJ 08540, US
Inventor
Name:
TUNG, RogerAddress:
Lexington, Massachusetts 02420, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
91513007 PDate:
1.5.2007Country:
US
Number:
91666207 PDate:
8.5.2007Country:
US
Number:
97604407 PDate:
28.9.2007Country:
US
Classification
Categories:
C07D 221/28, C07B 59/00, A61K 31/439, A61P 11/14
Annual fees
Number
Paid
Expires
Payer
Number: 17
Paid: 10.4.2024
Expires: 29.4.2025
Payer: Árnason Faktor ehf.
Number: 18
Paid: 14.4.2025
Expires: 29.4.2026
Payer: Árnason Faktor ehf.